Clinical Trials Logo

Clinical Trial Summary

This study is an observational study with the primary objective to assess the safety and tolerability of Ausanil in the treatment of primary headache disorders. The secondary objective is to assess headache pain, functional outcome, time loss to headache and patient satisfaction with Ausanil treatment.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02392273
Study type Observational
Source VR1 Corporation
Contact
Status Terminated
Phase N/A
Start date February 2015
Completion date January 2017

See also
  Status Clinical Trial Phase
Recruiting NCT05458817 - Digital-technology Based Interventions on Treatment of Migraine. N/A